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Section 1: Review of Literature to Identify Rehabilitation Need in Cancer Survivors 
  
Several studies support the need for additional wellness services for cancer survivors but 
there is a discrepancy between the literature and current healthcare practice. This literature 
review was conducted using the following search engines: CINAHL and Medline-PubMed. Key 
words used in the search included the following combinations of the words and terms: “physical 
distress,” “screening,” “cancer,” “rehabilitation,” and “wellness services.” Only scholarly journal 
articles were included, and the following restrictions were imposed on the search: human studies 
only and English language only. There were a total of 22 articles identified in CINAHL and 
Medline-PubMed that were related to physical distress screening in patients who have cancer. 
The following narrative is based on the inclusion of 11 articles published between 1997 and 2015 
that are reflective of the current body of evidence related to the incidence and need for physical 
distress screening in cancer populations. These articles were chosen because they displayed 
evidence that there is a lack of referral to additional wellness services for patients who have 
cancer despite a documented need in this population. 
More than 1.5 million people are diagnosed with cancer annually, and there are more than 
14.2 million cancer survivors in this country.1 With five-year survival rate estimates at an all-
time high and the number of survivors growing, the need to address issues facing cancer 
survivors has also grown in recognition. In Maine, approximately 8,810 individuals will be 
diagnosed with cancer in 2015.1 Each cancer survivor has a unique set of risk factors, disease 
presentation, course of treatment, and cancer treatment-related side effects requiring 
individualized, patient-centered care. Cancer is both an acute and chronic disease that requires 
attention from an interprofessional healthcare team. 
    People undergoing medical treatment for cancer are at high risk for severe and 
persistent symptoms of physical distress including fatigue, pain, loss of appetite, shortness of 
breath, numbness and tingling, cognitive and sexual dysfunction, constipation, muscle weakness, 
and gait disturbances that impair post-treatment function and may limit participation in 
rehabilitation programs.2, 3 Despite the need to identify and intervene with patients experiencing 
physical distress, there is a lack of referrals for additional wellness services.4 Many healthcare 
professionals do not view cancer as a chronic condition,5 even though cancer survivors can 
endure physical distress symptoms for up to ten years following treatment.6 Moreover, many 
healthcare professionals continue to view decreased quality of life in this population as an 
unavoidable outcome that accompanies the cancer diagnosis and treatment.6 Many clinicians 
focus solely on the cancer and not the presence of associated functional problems or residual 
impairments from intensive medical intervention.2 Oncologists may falsely assume that the 
patient is higher functioning than they actually are due to a lack of expertise to perform a full 
physical assessment.7 Physical and occupational therapists may also lack knowledge about 
disease progression in advanced cancer survivors. Functional losses are typically a slow and 
gradual process and may be unintentionally overlooked by members of the healthcare team.7 
    Pre-habilitation and rehabilitation can reduce physical distress and improve quality of 
life as well as physical and social functioning in cancer survivors.8, 9 Pre-habilitation is especially 
important because it focuses on strengthening and conditioning prior to treatment in order to 
minimize damage to the body and mind.10 Identifying the need for these rehabilitation 
interventions can be a challenge for both oncology and non-oncology healthcare providers alike. 
Developing systems to both identify and treat physical symptoms in oncology will be 
transformational for our growing cancer survivor patient population in need.  
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A study using population-based data from the Michigan Prostate Cancer Survivor Study 
(n=2,449) was performed to help determine the relationship between long-term prostate cancer 
survivors’ symptom burden and information needs.9 The results demonstrated a high symptom 
burden among all domains studied with over 56% of respondents reporting they needed more 
information regarding recurrence of disease, sexual relationships, and long-term effects.9 With 
the increasing population of long-term cancer survivors, addressing symptom burden is essential 
to ensure that each patient receives the appropriate healthcare services following diagnosis, as 
well as the proper patient education regarding symptom burden and management. 
    Impairment and disability are interrelated terms, though they can hold entirely different 
implications for each individual cancer survivor. For example, a mild impairment can cause a 
severe disability, while a severe impairment may cause a mild disability.8 For this reason, 
screening for early identification of impairments and how they directly relate to a patient’s 
current function may aide in the prevention of serious lifelong disabilities. The greatest source of 
emotional distress in cancer survivors is physical disability.11 The risk of psychological stress in 
individuals with cancer relates much more strongly to their level of disability than it does to the 
cancer diagnosis itself.11 Psychological distress screening in addition to physical screening is an 
important part of cancer care and whole-person treatment. Routine screenings and follow-up to 
encourage survivors to implement techniques and skills learned in their rehabilitative program 
may enhance an individual’s perspective on their quality of life. 
    The goal of this project, in collaboration with the Patrick Dempsey Center for Cancer 
Hope and Healing as well as the Rehabilitation Services and the Cancer Center at Central Maine 
Medical Center (CMMC), is to determine which physical distress screening tools are most 
appropriate to trigger a wellness or rehabilitation referral when it is warranted for a survivor. The 
use of effective screening tools will assist in directing cancer survivors, who experiencing 
physical and emotional burdens that are caused by the disease and subsequent treatment, to 
access services that will continue to improve their overall quality of life upon completion of 
cancer treatment or in a setting of ongoing palliative care.2 These measures should focus on 
functional mobility, balance, fatigue, and distress. Additionally, there are many common tests 
used to quantify the subjective burden of pain, confidence, and difficulty with daily tasks. 
Outcome measures such as these should be implemented throughout the course of treatment, 
with consistency, for patients with cancer to promote early recognition of impairments. Improved 
education for patients and healthcare providers alike on the services available, possible benefits 
of such referrals, and the importance of carefully selected measures to monitor functional change 
has the potential to begin to bridge the current gap between medical oncology treatment and the 
network of other rehabilitative healthcare services, as well as to improve the quality of life for 
our surviving family, friends, neighbors, coworkers, and colleagues. 
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Section 2: Review of Oncology Physical Distress Screening Tools and Outcome Measures 
  
This literature review was conducted using the following search engines: CINAHL, 
Medline-PubMed, and EBSCO. Key words used in the search included the following 
combinations of the words and terms “physical distress,” “screening,” “cancer,” “rehabilitation,” 
“wellness services,” “eastern cooperative oncology group scale,” “patient specific functional 
scale,” “fatigue,” “weakness,” “peripheral neuropathy,” “quality of life,” and “pain.” Only 
scholarly journal articles were included, and the following restrictions were imposed on the 
search: human studies only and English language only. There were 12 articles identified in 
EBSCO, CINAHL, and Medline-PubMed that were related to physical distress screening in 
patients who have cancer. Information was also included from websites such as the National 
Comprehensive Cancer Network (NCCN) and Rehab Measures. Additional articles were also 
identified through the reference lists of other articles and websites. The following narrative is 
based on the inclusion of 18 articles published between 1990 and 2015 that are reflective of the 
current body of evidence related to outcome measures and physical distress screening tools for 
cancer survivors. 
The need for referrals to additional wellness and rehabilitative services among cancer 
survivors is well documented in the literature, but there is currently no consensus on which 
screening tools and/or outcome measures should be used to help identify those who are in need 
of services. Cancer agencies, such as a the NCCN and the American Cancer Society provide 
guidelines for cancer care as it relates to specific diagnoses and symptoms, such as quality of 
life, fatigue, pain, distress, and survivorship.   However, there is little guidance on which tools 
should be used to detect physical distress and the role physical therapy can play in a survivor’s 
plan of care. 
Current Practice at Central Maine Medical Cancer Center 
Central Maine Medical Center (CMMC) currently utilizes the Eastern Cooperative 
Oncology Group Scale of Performance Status (ECOG), the Patient Specific Functional Scale 
(PSFS), and the National Comprehensive Cancer Network (NCCN) distress thermometer to 
assess physical and emotional distress and function in patients with cancer. The following 
describes those tools. 
The tool reportedly used most often by the oncology team at CMMC to assess function of 
patients is the ECOG (See Appendix 1). This scale is commonly used around the country in 
research settings when determining which patient population to include in trials of a new 
treatment method.1 However, our stakeholders at CMMC reported this is the primary tool for 
detecting change in a patient’s self-reported status and function. The ECOG was found to have 
fair interrater reliability (Kappa values greater than 0.40) between three oncologists with a 
population of 100 patients. All three oncologists were in complete agreement of a patient’s score 
for only 44 patients.2 This tool also encompasses a wide range of function, where 0 indicates no 
impairment and full activity and 5 indicates death. This tool is administered for each patient at 
CMMC when they check-in for appointments. Due to the multitude of abilities and disabilities a 
person may encounter as a result of their cancer treatment, a more sensitive tool may be 
beneficial to detect more subtle changes in patient status. As our technology and treatment 
methods develop, so to should the standard of our functional assessment. The need for increased 
referrals to address quality of life issues in this patient population has been discussed previously, 
and a more detailed performance scale will assist in ameliorating this gap. 
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The PSFS is a tool that is reportedly used during the initial patient visit following a 
cancer diagnosis, but is inconsistently administered at subsequent visits (See Appendix 2). This 
tool asks the patient to identify up to five activities they are having difficulty performing and rate 
the difficulty on a 0 to 10 scale, where 0 indicates they are unable to perform and 10 indicates 
they are able to perform at the same level as prior to their diagnosis. The PSFS is recommended 
to be re-administered at each subsequent visit to track changes in function specific to those 
activities. Despite excellent reliability (0.91), the PSFS has been primarily studied for patients 
with musculoskeletal injuries and the psychometric properties were determined as compared to 
other musculoskeletal outcome measures.4 No specific psychometric properties were found for 
the PSFS as it relates to impairments from cancer treatments. Many cancer survivors have 
musculoskeletal complaints, so the PSFS may still be an appropriate tool to use with this 
population. However, to keep the reliability of this measure relevant to the ever-fluctuating 
physical condition of this patient population, it must be administered on a more consistent and 
structured basis.  
The distress thermometer is recommended by the NCCN to screen for emotional, 
psychological, and physical distress (See Appendix 3).5 It includes a thermometer for the patient 
to rate their overall distress from 0 to 10, where 0 indicates no distress and 10 indicates extreme 
distress. It also includes a list of possible practical, family, emotional, spiritual/religious, and 
physical problems the patient could experience. The patient is asked to check yes if it is a 
problem or no if it is not a problem. Though this tool has good internal consistency (0.86) 6 it 
does not provide specific questions as to the nature of the patient’s problems or how often it 
interferes with their everyday life. This tool is currently being administered at CMMC upon 
initial diagnosis as well as at subsequent visits. It is reviewed by a licensed social worker, and is 
then sent to a doctor to generate referrals to other specialties, including rehabilitation, that the 
patient may need. 
Additional Outcome Measures 
Upon searching the literature, multitudes of screening tools and outcome measures exist 
that pertain to symptoms and impairments a cancer survivor may endure. The following are 
additional outcome measures that can be utilized once a symptom is identified on one of the pre-
existing screening tools (i.e. ECOG, PSFS, and/or the distress thermometer). These outcome 
measures may serve as a method to further determine a patient’s level of impairment with a 
given symptom and to better direct referrals to appropriate services.. 
Quality of Life 
A commonly used tool to assess quality of life in adult cancer survivors, specifically 
breast cancer survivors, is The Quality of Life in Adult Cancer Survivors scale (QLACS) (See 
Appendix 4). The QLACS scale is a psychometrically sound Quality of Life (QoL) instrument 
that assesses both acute and long-term concerns of cancer survivors. The QLACS scale was 
developed for long-term cancer survivors in response to limitations of QoL scales that focused 
mostly on acute diagnostic and treatment-related effects in cancer survivors.7 The QLACS scale 
has 47 items which comprise 12 domains. Seven of the domains include QoL components that 
reflect issues of importance to cancer survivors such as fatigue and cognitive and sexual 
problems, but purposely do not mention cancer to allow for comparison between survivors and 
the general population.7 The remaining five domains are cancer-specific and refer to cancer-
related concerns such as financial problems, family-related distress, recurrence-related distress, 
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and appearance concerns. A review of QoL instruments for long-term breast cancer survivors 
noted the QLACS scale had high internal consistency, high validity, and good responsiveness as 
well as test-retest reliability when compared to other QoL instruments used in this population.7 
This data suggests the QLACS scale is a promising comprehensive measure of QoL for early 
post-treatment breast cancer survivors.7 
 
The Reintegration to Normal Living Index (RNLI) is a patient reported outcome that 
aims to quantify the degree to which a patient has declined from their typical lifestyle and/or the 
degree to which they have been able to reintegrate into normal daily life, depending on where 
they are in the course of treatment (See Appendix 5).8 It consists of 11 declarative items, 8 items 
for activities of daily living and the remaining 3 items for self-perception.8 The RNLI has been 
found to have excellent concurrent validity (0.72) when used with Spitzer’s Quality of Life Index 
among patients with cancer.9 Though there is an opportunity for more research to be conducted 
on the reliability and validity of the RNLI for cancer patients, it has been shown to have good 
validity and reliability in assessing the community reintegration of adults living with subsequent 
impairments from chronic health conditions.9 From a healthcare system perspective, this test is 
inexpensive, quickly administered, and easily understood across disciplines and diverse patient 
demographics. 
Fatigue 
The NCCN recommends using a single item 0 to 10 point patient-report scale to 
document changes in fatigue (See Appendix 6).10 A score from 0 to 3 indicates none to mild 
fatigue, a score 4 to 6 indicates moderate fatigue, and a score 7 to 10 indicates severe fatigue. Per 
NCCN guidelines, a more focused assessment should be performed for patients who report a 
score of 4 or higher and education on fatigue management strategies should be provided to all 
patients. Our group was unable to find any information on reported psychometric properties for 
this tool. 
The Brief Fatigue Inventory (BFI) is a reliable self-report measure developed to quickly 
assess the severity of fatigue in individuals with cancer (See Appendix 7). Fatigue is rated on a 0 
to 10 numeric rating scale, with 0 indicating “no fatigue” and 10 indicating “fatigue as bad as 
you can imagine.”11 (p. 1188) Six items assess the amount that fatigue has interfered with different 
aspects of the patient’s life over the past 24 hours including: general activity, mood, walking 
ability, normal work (including work both inside or outside of the home), relationships with 
other people, and enjoyment of life.11 These items are also measured on a 0 to 10 scale, with 0 
indicating “does not interfere” and 10 indicating “completely interferes.”11 (p. 1188) The use of 
simple single word designations for severity of fatigue levels and functional domains make it 
easy to understand. The BFI has good psychometric properties such as good reliability (0.95), 
construct validity (0.81-0.92), and concurrent validity (0.84).11 Overall, the BFI is an effective 
clinical screening tool and can be used as an outcome measure in cases where fatigue severity is 
a primary concern. 
The Functional Assessment of Cancer Therapy - General (FACT-G) is an instrument 
commonly used to assess aspects of quality of life that may be impacted by cancer care, such as 
emotional, physical, and functional well being (See Appendix 8). There are many versions of the 
FACT that relate to specific cancer diagnoses, specific types of cancer treatment, and common 
symptoms associated with cancer and/or cancer treatment. Of the symptom-specific Functional 
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Assessment of Chronic Illness Therapy (FACIT) tools, the ones that relate to symptoms treatable 
by physical therapy include the FACIT-Fatigue (FACIT-F), FACIT-Anemia/Fatigue (FACIT-
An), and the FACIT-Lymphedema (FACIT-B+4) which is used in conjunction with the FACIT-
Breast Cancer. Many patients develop anemia and anemia-related symptoms with cancer or after 
cancer treatment.12 These specific 20-item questionnaires were developed to determine how 
fatigue and anemia-related symptoms impact a patient’s quality of life. Both FACIT-F (See 
Appendix 9) and FACIT-An (See Appendix 10) have strong internal consistency, 0.95 and 0.96 
respectively, as well as great test-retest reliability, 0.84 and 0.90 respectively.12 All versions of 
the FACT and FACIT questionnaires are relatively inexpensive and easy to administer. These are 
extremely useful tools in the healthcare system because they capitalize on the importance of the 
widespread problems with fatigue and anemia-related symptoms due to cancer and cancer 
treatment.12 
Pain 
The NCCN recommends utilizing the Numerical Pain Rating Scale (NPRS) in 
conjunction with the Faces Pain Rating Scale (FPRS) to assess for pain severity (See Appendix 
11).13 The NPRS is an 11-point scale where 0 indicates no pain and 10 indicates the worst pain 
imaginable. The NPRS and the FPRS have been found to have good to excellent reliability (0.88-
0.91) for patients with chronic neurogenic pain or acute pain.14 Though specific oncology 
populations were not assessed in this study, the results may still be applicable to oncology 
populations. 
The Brief Pain Inventory (BPI) has a short form version, which includes nine questions, 
and a long form version, which includes 32 questions (See Appendix 12). Both versions also 
include an outline of the anterior and posterior aspects of a body so the patient can report the 
specific location(s) of their pain. Both versions are free for clinical use and take the patient five 
to ten minutes to complete depending on which version is used. Among cancer patients and 
people with chronic pain, the BPI has adequate to excellent test-retest reliability and excellent 
internal consistency, which makes it a reliable tool to document changes in a patient’s pain. 
Neuropathy 
Neuropathy during cancer treatment is a common and debilitating side-effect often 
caused by chemotherapy occurring in 25% to 56% of cancer survivors receiving chemotherapy.16 
The Modified Total Neuropathy Score (mTNS) was developed to be a clinically feasible tool that 
has been shown to be a reliable and valid measure to evaluate the severity of chemotherapy-
induced peripheral neuropathy (See Appendix 13). The mTNS is simple, takes approximately 10 
minutes to administer, and has been shown to be correlated with the Total Neuropathy Score 
(TNS), TUG, and other QoL measures.16  
Weakness 
Manual muscle testing (MMT), as described by Kendall et al., is a method to assess a 
patient’s muscle strength. The grades range from 0, which indicates no movement or muscle 
contraction, to 5, which indicates the patient can hold the test position against gravity and strong 
pressure. MMT has been found to have good validity as well as excellent intrarater and interrater 
reliability when assessed in an orthopedic population.17 Though not specifically assessed in an 
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oncology population, this tool may still be appropriate to assess musculoskeletal impairments in 
cancer survivors. 
Grip strength is typically assessed through use of a hand-held dynamometer. It has been 
found to have excellent interrater and intrarater reliability as well as excellent test-retest 
reliability among various patient populations.18 Though psychometric properties as they pertain 
to oncology patient populations have not been developed, this may still be a valid tool to assess 
grip strength in cancer survivors. This test may be indicated for any patient with diminished grip 
or upper extremity strength to assess function, and it may be especially pertinent for patients with 
breast cancer who have had unilateral and/or bilateral axillary node dissection(s). 
In summary, cancer survivors often experience far-reaching and debilitating side effects 
of treatment that cause physical distress. Some of these side effects are directly related to 
treatment modalities, such as radiation and chemotherapy, while others are the result of cancer-
related surgical intervention or the tumor itself. Regardless of the source of impairment or 
functional limitation, healthcare professionals working with cancer survivors should be vigilant 
and prepared to deal with the high prevalence of physical distress in cancer survivors. A large 
body of evidence supports the effectiveness of screening tools to identify symptoms of physical 
distress. Referral to rehabilitation services, such as physical therapy, has repeatedly been shown 
to be effective in treating these symptoms. 
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Section 3a: Theories of Behavior Change 
This literature review was conducted using the following search engines: CINAHL, 
Medline-PubMed, and EBSCO. Key words used in the search included the following 
combinations of the words and terms: “physical distress,” “screening,” “cancer,” “rehabilitation,” 
“wellness services,” “health belief model,” and “diffusion of innovation theory.” Only scholarly 
journal articles were included, and the following restrictions were imposed on the search: human 
studies only and English language only. There were 5 articles identified in EBSCO, CINAHL, 
and Medline-PubMed that were related to the Health Belief Model and the Diffusion of 
Innovation Theory. Educational websites were also utilized. The following narrative is based on 
the inclusion of 5 articles published between 2009 and 2015 as well as one website that are 
reflective of the current body of evidence related to the Health Belief Model and the Diffusion of 
Innovation Theory. 
The Health Belief Model encompasses a person’s belief as it relates to the severity of a 
disease, the effectiveness or ineffectiveness of the recommended medical treatment, and 
willingness to overcome barriers to treatment.1 Through a stakeholder meeting with members 
from CMMC, it was determined that many of the barriers for referral to physical therapy services 
came from a lack of understanding of what physical therapy can do for the patient. Stated 
barriers included the perception that many cancer survivors will not want wellness services, 
difficulty of making referrals through their computer system, and the limited availability of a 
physical therapist within the cancer center to discuss the benefits of a physical therapy or 
wellness program with patients. These barriers have impeded the generation of referrals to 
additional wellness and rehabilitation services. 
The Diffusion of Innovation Theory is a community-level theory describing how new 
information is disseminated into a community.2 Our recommendation of increasing the frequency 
of screening tool administration to help healthcare professionals provide improved care to cancer 
survivors living with physical distress relies on early adopters and will likely face resistors. 
During our meeting it became clear that while some healthcare professions are eager to fill the 
gap in services for cancer survivors living with physical distress, others are resistant to change. 
The Diffusion of Innovation Theory matches well with this dynamic, describing how new 
evidence will be disseminated within these two groups. 
Through a review of literature, we determined which tests and measures are the most 
appropriate and effective to screen cancer survivors for physical distress and determine when a 
referral is indicated for additional wellness services (see Section 2). Several meetings have been 
held with our stakeholders at CMMC and the Dempsey Center, and it was determined there was 
a need to educate other members of the healthcare team on the benefits of rehabilitation and 
wellness programs to help generate an increase in referrals to those services. With the 
identification of a variety of outcome measures, it made it possible to focus our efforts on which 
tools would be most appropriate for CMMC and the most opportune time for these tools to be 
administered. By properly identifying those in need of rehabilitation services and making the 
appropriate referrals, the patient has the potential to benefit with an improved quality of life.  
Adopting new screening tools in a healthcare organization with established protocols is 
challenging. It often takes as long as twenty years between the development of evidence-based 
research and implementation into clinical practice.6 This means that although there is well-
published evidence that cancer survivors’ symptoms of physical distress are underreported, 3,4,5 it 
may be decades before automatic referrals for cancer survivors with physical distress becomes a 
standard of care. The Diffusion of Innovation Theory describes innovators and early adopters as 
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being critical in the early stages of implementation.2 These early adopters individually respond to 
and incorporate innovative ideas which leads to an eventual diffusion and change within the 
social system. This describes our situation accurately. Our group has identified innovative 
physical distress screening tools that will be used by rehabilitation clinicians at CMMC who are 
clearly motivated to lead the charge of adopting new and better ways of screening patients for 
physical distress. This will help lead to diffusion through the CMMC Cancer Center as people 
see the benefits of improved services for cancer survivors and increases in referrals. 
The Health Belief Model provides a framework for understanding the viewpoints of 
stakeholders at the Dempsey Center and CMMC. While this theory more directly applies to 
individuals making decisions about personal health behaviors, it provides insight into how 
stakeholders may view implementing a new protocol into their healthcare system. After we 
present our data on how to improve screening for physical distress to stakeholders, an evaluation 
of perceived benefits and barriers, perceived threat, and cues to action will guide perceptions of 
the feasibility of implementation. 
  
Section 3b: Program Delivery and Projected Impact 
A comprehensive list of screening tools has been identified as options for CMMC to use 
in identifying cancer survivors who would benefit most from rehabilitation services (see Section 
2). These tools may be utilized to improve upon the current method of needs identification 
among cancer survivors. Currently the ECOG is used as a standard within treatment sessions; 
however, it lacks the detailed information to truly determine those who would require 
rehabilitative care. The distress thermometer, which is also used by CMMC, is a more specific 
tool that, if used on a more consistent basis, could have more of an impact on the number of 
referrals to rehabilitation services.  
Systemic challenges we have identified with our stakeholders are that the current distress 
tools are not being used on a consistent basis, there is no set system to inform other healthcare 
professionals of the pertinent patient findings, and the ECOG is not sensitive enough to detect 
changes in physical distress in this patient population. This project aims to address this problem 
by providing other screening and outcome tool options that are more highly sensitive to common 
cancer treatment symptoms. A secondary challenge that arises is the lack of a person on staff 
who can take on the responsibility of selecting, administering, or appropriately passing forth the 
information gathered from these measurement tools, resulting in a necessary referral.  
The feasibility of this program is dependent upon a cancer survivor’s access to a 
healthcare professional who is trained and knowledgeable about administering the specific 
screening tools. In many cases, this may require that a rehabilitation professional be present in 
the primary cancer care setting. It is the recommendation of this group that the distress 
thermometer be administered to patients on a more consistent and structured basis in order to 
better detect changes in physical distress throughout their continuum of care. This project also 
identifies the long-term solutions to be the implementation and inclusion of a rehabilitation 
professional on the interdisciplinary oncology rehabilitation team at CMMC. This rehabilitation 
professional would be present within the infusion center to administer appropriate screening 
tools, and have conversations with patients and their families who are experiencing distress and 
may benefit from rehabilitation services. The projected impact of this project will be dependent 
on follow-through with CMMC’s physical therapy department and the Cancer Center. By 
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incorporating a physical therapist into the routine care for cancer survivors there is potential for 
increased referrals to physical therapy and an improved quality of life for those patients. 
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Section 4: Methods of Program Evaluation 
Success of this program will be dependent upon CMMC adopting policy changes to 
include rehabilitation professionals, such as physical therapists, occupational therapists, and 
speech and language pathologists, as members of the healthcare team upon initial cancer 
diagnosis. This will allow for early access to screen survivors for symptoms of physical distress 
and provide an opportunity for early education on symptom burden management. It will also 
provide access to rehabilitation services throughout the patient’s cancer care with regular follow-
ups and screening. Ultimately, success of this program will be evident by an increase in referrals 
to rehabilitation and wellness services, a decrease in hospital readmission rates, and, most 
importantly, a better overall quality of life for cancer survivors. 
  
Outputs: 
Our group performed two needs assessment meetings with stakeholders at CMMC and 
the Dempsey Center. These stakeholders included the director of outpatient rehabilitation 
services at CMMC, the nurse manager at the CMMC infusion center, two medical oncology 
nurse practitioners at CMMC, and the executive director of the Dempsey Center. These meetings 
demonstrated a need to clarify which screening tools best identify physical distress in cancer 
survivors. The final product for this project will be a one-hour presentation attended by 
approximately 10 members of our stakeholders to discuss utilization of physical distress 
screening tools and a pilot of implementing a physical therapist during chemotherapy infusion at 
the CMMC Cancer Center. 
  
Outcomes: 
Short-term: 
 We will measure the outcome of our program by the number of stakeholders present for 
our presentation, the overall professional response across disciplines, and feedback received 
from the attending audience to implement some or all of our recommendations. The collective 
information gathered at prior meetings and a literature review served as the foundation for our 
stakeholder presentation on December 4th, 2015 at CMMC.  
  
Medium-term: 
The integration of rehabilitation and wellness services will be measured by the number of 
referrals generated to rehabilitation services. Following the addition of a part-time physical 
therapist to the CMMC infusion team, our goal is to increase the number of monthly oncology 
referrals to rehabilitation and wellness services by 10%.   
  
Long-term: 
Long-term outcomes include employment of a full-time physical therapist in the CMMC 
Cancer Center where every cancer survivor is screened for signs of physical distress weekly and 
an increase in referrals to rehabilitative and wellness services. Standardization of rehabilitation 
and wellness services will be measured by reassessing baselines in 2020 for goal 14 in the Maine 
Cancer Control Plan. Assessments will be made through the Maine Cancer Consortium’s 
Activity Tracker, as well as phone calls and e-mails to cancer treating hospitals, as needed. 
Decreased public healthcare financial burden will be measured by annual economic assessments. 
The quality of life of cancer survivors will be measured by annual quality of life outcome 
assessments. 
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Logical Model 
This model will encompass a basis for selection of screening tools for this population. 
This model is based upon the International Classification of Functioning Disability and Health 
(ICF) model. Components of this model are patient-centered and include the following: health 
condition, body function and structure, activity limitations and participation restrictions, 
environmental factors, and personal factors. This model will provide a framework that can be 
used across all disciplines in order to standardize language and concepts to improve patient 
quality of life. Utilizing the ICF framework can help guide rehabilitation services in choosing 
appropriate outcome measures that are useful in assessing patients for physical distress with an 
oncology diagnosis.
  
This model is dependent on CMMC adopting behavior change in order for rehabilitation 
services to become a cohesive part of the cancer care team. 
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Appendix 1 
Eastern Cooperative Oncology Group Scale of Performance Status (ECOG) 
 
 
From: http://ecog-acrin.org/resources/ecog-performance-status 
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Appendix 2 
Patient Specific Functional Scale (PSFS)  
 
 
From: http://www.tac.vic.gov.au/__data/assets/pdf_file/0020/27317/Patient-specific.pdf 
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Appendix 3 
NCCN Distress Thermometer 
 
 
 
From: http://www.nccn.org/patients/resources/life_with_cancer/pdf/nccn_distress_thermometer.pdf 
 
 22 
Appendix 4 
The Quality of Life in Adult Cancer Survivors scale (QLACS) 
 
INSTRUCTIONS: We’d like to ask you about some things that can affect the quality of people’s 
lives. Some of these questions may sound similar, but please be sure to answer each one. Below 
is a scale ranging from “never” to “always”. Please indicate how often each of these statements 
has been true for you in the past four weeks. [Choose one answer for each question] 
 
1 = never 2 = seldom 3 = sometimes  4 = about as often as not 5 = frequently  
6 = very often 7 = always 
 
In the past 4 weeks … 
 
1. You had the energy to do the things you wanted to do. 
2. You had difficulty doing activities that require concentrating. 
3. You were bothered by having a short attention span. 
4. You had trouble remembering things. 
5. You felt fatigued. 
6. You felt happy. 
7. You felt blue or depressed. 
8. You enjoyed life. 
9. You worried about little things. 
10. You were bothered by being unable to function sexually. 
11. You didn’t have energy to do the things you wanted to do. 
12. You were dissatisfied with your sex life. 
13. You were bothered by pain that kept you from doing the things you wanted to do. 
14. You felt tired a lot. 
15. You were reluctant to start new relationships. 
16. You lacked interest in sex. 
17. Your mood was disrupted by pain or its treatment. 
18. You avoided social gatherings. 
19. You were bothered by mood swings. 
20. You avoided your friends. 
21. You had aches or pains. 
22. You had a positive outlook on life. 
23. You were bothered by forgetting what you started to do. 
24. You felt anxious. 
25. You were reluctant to meet new people. 
26. You avoided sexual activity. 
27. Pain or its treatment interfered with your social activities. 
28. You were content with your life. 
 
The next set of questions asks specifically about the effects of your cancer or its treatment. 
Again, for each statement, indicate how often each of these statements has been true for you in 
the past four weeks. 
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29. You appreciated life more because of having had cancer. 
30. You had financial problems because of the cost of cancer surgery or treatment. 
31. You worried that your family members were at risk of getting cancer. 
32. You realized that having had cancer helps you cope better with problems now. 
33. You were self-conscious about the way you look because of your cancer or its treatment. 
34. You worried about whether your family members might have cancer-causing genes. 
35. You felt unattractive because of your cancer or its treatment. 
36. You worried about dying from cancer. 
37. You had problems with insurance because of cancer. 
38. You were bothered by hair loss from cancer treatment. 
39. You worried about cancer coming back. 
40. You felt that cancer helped you to recognize what is important in life. 
41. You felt better able to deal with stress because of having had cancer. 
42. You worried about whether your family members should have genetic tests for cancer. 
43.  You had money problems that arose because you had cancer. 
44. You felt people treated you differently because of changes to your appearance due to 
your cancer or its treatment. 
45. You had financial problems due to a loss of income as a result of cancer. 
46. Whenever you felt a pain, you worried that it might be cancer again. 
47. You were preoccupied with concerns about cancer. 
 
Scales are computed as follows: 
 
Negative feelings, items 7, 9, 19, and 24 
Positive feelings, items 6, 8, 22, and 28 
Cognitive Problems, items 2, 3, 4, and 23 
Pain, items 13, 17, 21, and 27 
Sexual Interest, items 16 and 26 
Energy/Fatigue, items 1 (reversed), 5, 11, and 14 
Sexual Function, items 10 and 12 
Social Avoidance, items 15, 18, 20, and 25 
Financial Problems, items 30, 37, 43, and 45 
Benefits, items 29, 32, 40, and 41 
Distress-Family, items 31, 34, and 42 
Appearance, items 33, 35, 38, and 44 
Distress-Recurrence, items 36, 39, 46, and 47 
 
From: http://www.psy.miami.edu/faculty/ccarver/sclQLACS.html 
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Appendix 5 
Reintegration to Normal Living Index (RNLI) 
 
1. I move around my living quarters as I feel is necessary (Wheelchairs, other equipment or resources may be used.) 
2. I move around my community as I feel is necessary. (Wheelchairs, other equipment or resources may be used.) 
3. I am able to take trips out of town as I feel are necessary. (Wheelchairs, other equipment or resources may be used.) 
4. I am comfortable with how my self-care needs (dressing, feeding, toileting, bathing) are met. (Adaptive equipment, 
supervision and/or assistance may be used.) 
5. I spend most of my days occupied in a work activity that is necessary or important to me. (Work activity could be paid 
employment, housework, volunteer work, school, etc. Adaptive equipment, supervision and/or assistance may be used.) 
6. I am able to participate in recreational activities (hobbies, crafts, sports, reading, television, games, computers, etc.) as I want 
to. (Adaptive equipment, supervision and/or assistance may be used.) 
7. I participate in recreational activities (hobbies, crafts, sports, reading, television, games, computers, etc.) as I want to. 
(Adaptive equipment, supervision and/or assistance may be used.) 
8. I assume a role in my family which meets my needs and those of other family members. (Family means people with whom you 
live and/or relatives with whom you don’t live but see on a regular basis. Adaptive equipment, supervision and/or assistance 
may be used.) 
9. In general, I am comfortable with my personal relationships. 
10. In general, I am comfortable with myself when I am in the company of others. 
11. I feel that I can deal with life events as they happen.  
 
 
 
From: http://www.strokengine.ca/pdf/rnli.pdf 
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Appendix 6 
NCCN-Recommended Fatigue Patient-Report Scale 
 
“How would you rate your fatigue on a scale of 0-10 over the past 7 days?” 
 
Adults >12 years old: 
0 = No fatigue 
1-3 = Mild fatigue 
4-6 = Moderate fatigue 
7-10 = Severe fatigue where 10 = the worst fatigue you can imagine 
 
Children 7-12 years old: 
1 = No fatigue 
5 = Worst 
 
Children 5-6 years old: 
Tired or Not tired 
 
From: http://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf 
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Appendix 7 
Brief Fatigue Inventory (BFI) 
 
 
From: http://www.npcrc.org/files/news/brief_fatigue_inventory.pdf 
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Appendix 8 
Functional Assessment of Cancer Therapy - General (FACT-G) 
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From: http://www.facit.org/FACITOrg/Questionnaires 
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Appendix 9 
Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) 
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From: http://www.facit.org/FACITOrg/Questionnaires 
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Appendix 10 
Functional Assessment of Chronic Illness Therapy - Anemia/Fatigue (FACIT-An) 
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From: http://www.facit.org/FACITOrg/Questionnaires 
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Appendix 11 
Numerical Pain Rating Scale (NPRS) 
 
 
 
From: 
http://www.rehabmeasures.org/PDF%20Library/Numeric%20Pain%20Rating%20Scale%20Instr
uctions.pdf 
  
 36 
Appendix 12 
Brief Pain Inventory Short Form (BPI) 
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From: http://www.npcrc.org/files/news/briefpain_short.pdf 
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Appendix 13 
Modified Total Neuropathy Score (mTNS) 
 
 
 
From: http://joannabriggslibrary.org/index.php/jbisrir/article/view/1486/1976 
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Appendix 14 
Manual Muscle Testing (MMT) 
 
 
 
From: http://www.prohealthcareproducts.com/blog/manual-muscle-testing-grading-chart-
florence-kendall/ 
 
